Top Stories
India
India
Natco Pharma invests $14mn in biotech firm eGenesis; total investment at $22mn
eGenesis is developing genome-engineered organs aimed at addressing the global shortage of transplantable organs and improving treatment options for patients suffering from organ failure.
Continue Reading on The Hindu
This article is aggregated from The Hindu. Click below to read the full story.
India Today
